BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26800081)

  • 1. Rapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.
    Belondrade M; Nicot S; Béringue V; Coste J; Lehmann S; Bougard D
    PLoS One; 2016; 11(1):e0146833. PubMed ID: 26800081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies.
    Bélondrade M; Jas-Duval C; Nicot S; Bruyère-Ostells L; Mayran C; Herzog L; Reine F; Torres JM; Fournier-Wirth C; Béringue V; Lehmann S; Bougard D
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31996421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A direct assessment of human prion adhered to steel wire using real-time quaking-induced conversion.
    Mori T; Atarashi R; Furukawa K; Takatsuki H; Satoh K; Sano K; Nakagaki T; Ishibashi D; Ichimiya K; Hamada M; Nakayama T; Nishida N
    Sci Rep; 2016 Apr; 6():24993. PubMed ID: 27112110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.
    Douet JY; Lacroux C; Aron N; Head MW; Lugan S; Tillier C; Huor A; Cassard H; Arnold M; Beringue V; Ironside JW; Andréoletti O
    Emerg Infect Dis; 2017 Jun; 23(6):946-956. PubMed ID: 28518033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.
    Wadsworth JD; Dalmau-Mena I; Joiner S; Linehan JM; O'Malley C; Powell C; Brandner S; Asante EA; Ironside JW; Hilton DA; Collinge J
    J Pathol; 2011 Mar; 223(4):511-8. PubMed ID: 21294124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro bioassay systems for the amplification and detection of abnormal prion PrP(Sc) in blood and tissues.
    Zhang W; Wu J; Li Y; Carke RC; Wong T
    Transfus Med Rev; 2008 Jul; 22(3):234-42. PubMed ID: 18572098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of vCJD Strain Properties After Extraction and In Vitro Propagation of PrP
    Suleiman S; McGuire LI; Chong A; Ritchie DL; Boyle A; McManus L; Brydon F; Smith C; Knight R; Green A; Diack AB; Barria MA
    Mol Neurobiol; 2023 Nov; 60(11):6275-6293. PubMed ID: 37442858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme-detergent method for effective prion decontamination of surgical steel.
    Jackson GS; McKintosh E; Flechsig E; Prodromidou K; Hirsch P; Linehan J; Brandner S; Clarke AR; Weissmann C; Collinge J
    J Gen Virol; 2005 Mar; 86(Pt 3):869-878. PubMed ID: 15722550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing surgical instrument safety: A screen of oxidative and alkaline prion decontaminants using real-time quaking-induced conversion with prion-coated steel beads as surgical instrument mimetic.
    Heinzer D; Avar M; Pfammatter M; Moos R; Schwarz P; Buhmann MT; Kuhn B; Mauerhofer S; Rosenberg U; Aguzzi A; Hornemann S
    PLoS One; 2024; 19(6):e0304603. PubMed ID: 38870196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.
    Giaccone G; Moda F
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32151109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces.
    Lemmer K; Mielke M; Pauli G; Beekes M
    J Gen Virol; 2004 Dec; 85(Pt 12):3805-3816. PubMed ID: 15557254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease.
    Yokoyama T; Takeuchi A; Yamamoto M; Kitamoto T; Ironside JW; Morita M
    Neurosci Lett; 2011 Jul; 498(2):119-23. PubMed ID: 21565253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
    Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
    Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.
    Bougard D; Brandel JP; Bélondrade M; Béringue V; Segarra C; Fleury H; Laplanche JL; Mayran C; Nicot S; Green A; Welaratne A; Narbey D; Fournier-Wirth C; Knight R; Will R; Tiberghien P; Haïk S; Coste J
    Sci Transl Med; 2016 Dec; 8(370):370ra182. PubMed ID: 28003547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin.
    Oshita M; Yokoyama T; Takei Y; Takeuchi A; Ironside JW; Kitamoto T; Morita M
    Transfusion; 2016 Jan; 56(1):223-30. PubMed ID: 26347231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.
    Halliez S; Reine F; Herzog L; Jaumain E; Haïk S; Rezaei H; Vilotte JL; Laude H; Béringue V
    J Virol; 2014 Aug; 88(15):8678-86. PubMed ID: 24850746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel copper-hydrogen peroxide formulation for prion decontamination.
    Solassol J; Pastore M; Crozet C; Perrier V; Lehmann S
    J Infect Dis; 2006 Sep; 194(6):865-9. PubMed ID: 16941355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a fluorescent dual stain to assess decontamination of tissue protein and prion amyloid from surgical stainless steel during simulated washer-disinfector cycles.
    Howlin RP; Khammo N; Secker T; McDonnell G; Keevil CW
    J Hosp Infect; 2010 May; 75(1):66-71. PubMed ID: 20303614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.